Boston Partners Trinity Biotech PLC Transaction History

Boston Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$1.57 - $3.02 $709,886 - $1.37 Million	-452,157 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$2.31 - $3.22 $215,677 - $300,641	-93,367 Reduced 17.12%	452,157 $1.29 Million
Q4 2018 Feb 07, 2019	SELL	$2.14 - $4.26 $273,055 - $543,558	-127,596 Reduced 18.96%	545,524 $1.25 Million
Q3 2018 Nov 14, 2018	SELL	$3.76 - $5.08 $611,526 - $826,211	-162,640 Reduced 19.46%	673,120 $2.69 Million
Q2 2018 Aug 03, 2018	SELL	$4.46 - $5.2 $68,550 - $79,924	-15,370 Reduced 1.81%	835,760 $4.18 Million
Q1 2018 May 04, 2018	SELL	$5.08 - $6.06 $1.13 Million - $1.35 Million	-223,090 Reduced 20.77%	851,130 $4.38 Million
Q4 2017 Feb 01, 2018	SELL	$4.5 - $5.77 $767,956 - $984,690	-170,657 Reduced 13.71%	1,074,220 $5.49 Million
Q3 2017 Nov 02, 2017	BUY	$5.16 - $5.67 $6.42 Million - $7.06 Million	1,244,877	1,244,877 $6.98 Million

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.